XSWX
CLTN
Market cap375mUSD
Jul 10, Last price
49.55CHF
1D
-2.27%
1Q
-2.27%
Jan 2017
-33.09%
IPO
-43.69%
Name
Coltene Holding AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
COLTENE Holding AG, established in 2005 and headquartered in Altstätten, Switzerland (and previously known as Medisize Holding AG until April 2008), is a global enterprise dedicated to the design, production, and sale of an extensive range of consumables, instruments, and specialized equipment for dentists and dental laboratories. The company serves a broad international market spanning Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. Its comprehensive product offerings address diverse areas of dental practice: Restorative Dentistry: Includes various conventional and bulk-fill composites, CAD/CAM solutions, bonding agents, etching gels, temporary filling materials, luting, and curing lights. Endodontics: Encompasses posts, rotary and hand files, irrigation and obturation solutions, sealing materials, Gutta-percha and paper points, endo engines, and apex locators. Prosthetic Dentistry: Features materials for bite registration, A- and C-silicones, and related accessories. Treatment Auxiliaries: Provides essential items such as dental rolls, cotton products, aspirator tips, dental dams, scalers, electrosurgery units, and occlusion verification tools. Infection Control: Offers products like ultrasonic cleaning units, patient bibs, headrest covers, and sterile covers. Rotary Instruments: Supplies diamond and carbide burs, polishers, and specialized kits. Laboratory Products: Covers gingiva masks, lab putty, model making materials, waxes, HP burs, and silicone polishers for dental lab applications.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||